Chronopharmacology in Therapeutic Drug Monitoring—Dependencies between the Rhythmics of Pharmacokinetic Processes and Drug Concentration in Blood
The objective of the optimization of pharmacotherapy compliant with the basic rules of clinical pharmacology is its maximum individualization, ensuring paramount effectiveness and security of the patient’s therapy. Thus, multiple factors that are decisive in terms of uniqueness of treatment of the g...
Guardado en:
Autor principal: | |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/838a83b98d4f42dbabe419ba6ab7261e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:838a83b98d4f42dbabe419ba6ab7261e |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:838a83b98d4f42dbabe419ba6ab7261e2021-11-25T18:41:46ZChronopharmacology in Therapeutic Drug Monitoring—Dependencies between the Rhythmics of Pharmacokinetic Processes and Drug Concentration in Blood10.3390/pharmaceutics131119151999-4923https://doaj.org/article/838a83b98d4f42dbabe419ba6ab7261e2021-11-01T00:00:00Zhttps://www.mdpi.com/1999-4923/13/11/1915https://doaj.org/toc/1999-4923The objective of the optimization of pharmacotherapy compliant with the basic rules of clinical pharmacology is its maximum individualization, ensuring paramount effectiveness and security of the patient’s therapy. Thus, multiple factors that are decisive in terms of uniqueness of treatment of the given patient must be taken into consideration, including, but not limited to, the patient’s age, sex, concomitant diseases, special physiological conditions (e.g., pregnancy, lactation, extreme age groups), polypharmacotherapy and polypragmasia (particularly related to increased risk of drug interactions), and patient’s phenotypic response to the administered drug with possible genotyping. Conducting therapy while monitoring the concentration of certain drugs in blood (Therapeutic Drug Monitoring; TDM procedure) is also one of the factors enabling treatment individualization. Furthermore, another material, and yet still a marginalized pharmacotherapeutic factor, is chronopharmacology, which indirectly determines the values of drug concentrations evaluated in the TDM procedure. This paper is a brief overview of chronopharmacology, especially chronopharmacokinetics, and its connection with the clinical interpretation of the meaning of the drug concentrations determined in the TDM procedure.Lukasz DobrekMDPI AGarticlechronopharmacologycircadian rhythmtherapeutic drug monitoringchronopharmacokineticsPharmacy and materia medicaRS1-441ENPharmaceutics, Vol 13, Iss 1915, p 1915 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
chronopharmacology circadian rhythm therapeutic drug monitoring chronopharmacokinetics Pharmacy and materia medica RS1-441 |
spellingShingle |
chronopharmacology circadian rhythm therapeutic drug monitoring chronopharmacokinetics Pharmacy and materia medica RS1-441 Lukasz Dobrek Chronopharmacology in Therapeutic Drug Monitoring—Dependencies between the Rhythmics of Pharmacokinetic Processes and Drug Concentration in Blood |
description |
The objective of the optimization of pharmacotherapy compliant with the basic rules of clinical pharmacology is its maximum individualization, ensuring paramount effectiveness and security of the patient’s therapy. Thus, multiple factors that are decisive in terms of uniqueness of treatment of the given patient must be taken into consideration, including, but not limited to, the patient’s age, sex, concomitant diseases, special physiological conditions (e.g., pregnancy, lactation, extreme age groups), polypharmacotherapy and polypragmasia (particularly related to increased risk of drug interactions), and patient’s phenotypic response to the administered drug with possible genotyping. Conducting therapy while monitoring the concentration of certain drugs in blood (Therapeutic Drug Monitoring; TDM procedure) is also one of the factors enabling treatment individualization. Furthermore, another material, and yet still a marginalized pharmacotherapeutic factor, is chronopharmacology, which indirectly determines the values of drug concentrations evaluated in the TDM procedure. This paper is a brief overview of chronopharmacology, especially chronopharmacokinetics, and its connection with the clinical interpretation of the meaning of the drug concentrations determined in the TDM procedure. |
format |
article |
author |
Lukasz Dobrek |
author_facet |
Lukasz Dobrek |
author_sort |
Lukasz Dobrek |
title |
Chronopharmacology in Therapeutic Drug Monitoring—Dependencies between the Rhythmics of Pharmacokinetic Processes and Drug Concentration in Blood |
title_short |
Chronopharmacology in Therapeutic Drug Monitoring—Dependencies between the Rhythmics of Pharmacokinetic Processes and Drug Concentration in Blood |
title_full |
Chronopharmacology in Therapeutic Drug Monitoring—Dependencies between the Rhythmics of Pharmacokinetic Processes and Drug Concentration in Blood |
title_fullStr |
Chronopharmacology in Therapeutic Drug Monitoring—Dependencies between the Rhythmics of Pharmacokinetic Processes and Drug Concentration in Blood |
title_full_unstemmed |
Chronopharmacology in Therapeutic Drug Monitoring—Dependencies between the Rhythmics of Pharmacokinetic Processes and Drug Concentration in Blood |
title_sort |
chronopharmacology in therapeutic drug monitoring—dependencies between the rhythmics of pharmacokinetic processes and drug concentration in blood |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/838a83b98d4f42dbabe419ba6ab7261e |
work_keys_str_mv |
AT lukaszdobrek chronopharmacologyintherapeuticdrugmonitoringdependenciesbetweentherhythmicsofpharmacokineticprocessesanddrugconcentrationinblood |
_version_ |
1718410783707103232 |